0001209191-23-003851.txt : 20230118
0001209191-23-003851.hdr.sgml : 20230118
20230118190328
ACCESSION NUMBER: 0001209191-23-003851
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230113
FILED AS OF DATE: 20230118
DATE AS OF CHANGE: 20230118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brandenberger Ralph
CENTRAL INDEX KEY: 0001853197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 23535560
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 102
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-582-4923
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-13
0
0001787400
Nkarta, Inc.
NKTX
0001853197
Brandenberger Ralph
C/O NKARTA, INC.
6000 SHORELINE COURT, SUITE 102
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Technical Officer
Common Stock
2023-01-13
4
A
0
21000
0.00
A
28800
D
Common Stock
2023-01-17
4
S
0
491
5.49
D
28309
D
Stock Option (right to buy)
5.57
2023-01-13
4
A
0
42000
0.00
A
2033-01-12
Common Stock
42000
42000
D
Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on January 14, 2024. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a discretionary transaction by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $5.49 to $5.65. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2023.
/s/ Alicia Hager, as Attorney-in-Fact
2023-01-18